Marie B. Buen-Bigornia

FDA investigator

Appears on 7 documents from 2011 to 2019, most often at sites in Colorado. Most often cites general requirements (21 CFR 211.160).

7
Documents on file
5.3
Observations per 483
2011
First seen
2019
Most recent

What they cite most

From 32 observations

Activity by year

2011: 2, 2013: 1, 2016: 2, 2018: 1, 2019: 1

Where

Colorado 3 · India 2 · Illinois 1 · New York 1

Is Marie B. Buen-Bigornia coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 EUGIA PHARMA SPECIALITIES LIMITEDNov 13, 2019 · Sangareddy, India
483 Amneal Pharmaceuticals Private LimitedApr 24, 2018 · Ahmedabad, India
483 Hi-Tech Pharmacal, an AKORN CompanyJul 15, 2016 · Amityville, New York
483 Xttrium Laboratories, IncJul 11, 2016 · Mount Prospect, Illinois
483 Front Range Laboratories, IncorporatedAug 30, 2013 · Loveland, Colorado
EIR Sparboe Farms, Inc.May 12, 2011 · Hudson, Colorado
483 Sparboe Farms, IncMay 12, 2011 · Hudson, Colorado

About this profile

What does Marie B. Buen-Bigornia inspect?

Marie B. Buen-Bigornia appears on 7 documents on file covering 6 sites, most often in Colorado.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.25 and 21 CFR 118.10(a)(3)(ii).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Marie B. Buen-Bigornia is dated Nov 13, 2019.